S. 3237 · 112th Congress
Accelerating the End of Breast Cancer Act of 2012
Key: what the circles and colors mean
Each circle is a bill. The ring fills as it moves through Congress:
Under the number: the Yea · Nay count of its final (or latest) recorded vote. On a member's page, the small badge is how that member voted: Y Yea / Aye, N Nay / No, P Present, – Not voting.
Gold and violet are only for Yea and Nay; they never mean a party. A member's party is the letter on their photo.
Never voted on. It didn't reach a floor vote before the 112th Congress ended, so it expired. A bill has to be introduced again to be considered in a new Congress.
D
WhitehouseSponsor26 cosponsors · 19 D, 6 R, 1 I
D
Brown
SC
R
Collins
CG
R
Grassley
DH
R
Heller
LM
R
Murkowski
JS
D
Shaheen
MW
D
Warner
BB
D
Boxer
JR
D
Reed
AF
D
Franken
CS
D
Schumer
MB
D
Begich
BM
D
Menendez
KG
D
Gillibrand
BC
D
Casey
JT
D
Tester
RB
D
Blumenthal
OS
R
Snowe
JK
D
Kerry
ML
D
Landrieu
HK
D
Kohl
AK
D
Klobuchar
SB
R
Brown
FL
D
Lautenberg
BS
I
Sanders
JM
D
Merkley7 signed on when it was introduced; the rest joined later. Cosponsors who withdrew aren't shown.
Accelerating the End of Breast Cancer Act of 2012 - Establishes the Commission to Accelerate the End of Breast Cancer to help end breast cancer by January 1, 2020.
What it does: CRS summary · Introduced in Senate · May 24, 2012
Accelerating the End of Breast Cancer Act of 2012 - Establishes the Commission to Accelerate the End of Breast Cancer to help end breast cancer by January 1, 2020.
Directs the Commission to: (1) identify opportunities and ideas within the public and private sectors, basic and applied sciences, and epidemiology that can be turned into real world strategies to prevent breast cancer and breast cancer metastasis; (2) recommend projects to leverage such opportunities and ideas in the areas of the primary prevention of breast cancer and the causes and prevention of breast cancer metastasis; (3) promote ideas that are intellectually compelling and innovative; (4) accelerate potentially transformational scientific advances that are not being prioritized within the federal government and that are unlikely to be achieved by the private sector; (5) identify promising but underdeveloped areas of research that would benefit from a cluster of support from government, industry, and academia to rapidly advance knowledge into practices; (6) create opportunities for transdisciplinary, cross-cutting collaborations; (7) submit its strategic vision within six months after its initial members are appointed; and (8) ensure that its activities are coordinated with, and do not duplicate the efforts of, programs and laboratories of other government agencies.
Directs the President to enter into an agreement with the Institute of Medicine for an evaluation of the Commission's progress.
Establishes the Accelerating the End of Breast Cancer Fund to carry out this Act.
Terminates the Commission on June 1, 2020.
Written by the nonpartisan Congressional Research Service. All summary versions on Congress.gov
About this bill and sources
Official title: Accelerating the End of Breast Cancer Act of 2012
Latest action (May 24, 2012): Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Policy area: Health · Origin: Senate · Introduced: May 24, 2012
Official page on Congress.gov · Bill text (GovInfo) · Status record (XML)
No recorded floor vote found.